Pharmafile Logo
Pharmafocus logo
Advanced Search

The golden rules of PR

June 29, 2005
Medical Communications

In light of the enormous potential brand benefits of pharma PR,  the question should not be 'Shall we invest in …

Feature

Humira receives two European recommendations

June 29, 2005
Sales and Marketing

Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …

News

All aboard the health train

June 29, 2005
Medical Communications

Making friends and influencing people is an area, it's widely agreed, where big pharma could do better. Few companies, however, …

Feature

New products key to Schering growth

June 29, 2005
Sales and Marketing

Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …

News

FDA approves new HIV drug Aptivus

June 29, 2005
Sales and Marketing

Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …

News

GSK forms hypertension alliance

June 29, 2005
Sales and Marketing

GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …

News

FDA approves first ‘ethnic’ heart drug

June 29, 2005
Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …

News

Woolley Pau wins Chiron campaign

June 29, 2005
Medical Communications

Woolley Pau has been appointed by Chiron Biopharma Europe to work on a pan-European launch campaign, following a four-way pitch.A …

News

People Strategies launch

June 28, 2005
Sales and Marketing

A new company has been launched to bring people and change management expertise to companies that are not able to …

News

Seven Stones expands into market research with Strata

June 28, 2005
Medical Communications

Healthcare communications agency Seven Stones has launched a new market research company to be run by a former head of …

News

Public involvement part of Labour’s vision for primary care

June 28, 2005

Health secretary Patricia Hewitt has announced plans for a major public engagement exercise to help make far-reaching changes to primary …

News

NHS chief executives call for an extension of patient choice

June 28, 2005

An overwhelming majority of NHS chief executives believe patient choice should be extended to treatment as well as service providers, …

News

Roche’s Tarceva approaches EU approval

June 28, 2005
Sales and Marketing

Roche's new oral cancer treatment Tarceva has received a recommendation from the EMEA's advisory committee, paving the way for its …

News

Pfizer hits out at NICE’s statin guidance

June 28, 2005
Sales and Marketing

News

The myth of the ‘S-shaped’ curve

June 28, 2005
Sales and Marketing

Feature

AstraZeneca’s defeat opens door to more challenges

June 24, 2005
Sales and Marketing

Pharmaceutical companies found guilty of violating European antitrust laws can expect steeper fines than AstraZeneca, according to a leading law …

News

Side-effect doubts cloud future of Pargluva and Galida

June 24, 2005
Sales and Marketing

A study comparing novel treatment Pargluva with a best-selling diabetes drug has yielded some positive results for the new drug, …

News

Acomplia filed in Europe and US

June 24, 2005
Sales and Marketing

Sanofi-Aventis has submitted its new obesity treatment Acomplia to the European Union and US regulators.Even before its filing Acomplia (rimonabant) …

News

Novartis hails new MS pill as a breakthrough

June 23, 2005
Sales and Marketing

Novartis says its new multiple sclerosis  treatment is more effective than existing drugs in delaying the progress of the disease, …

News

New NHS Innovation and Improvement czar appointed

June 23, 2005

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026